News
A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...
Amycretin, a new weight-loss treatment from Novo Nordisk, combines two hunger hormones, helping participants lose nearly ...
For patients with IIH, sustainable weight loss offers the most effective and lasting relief from symptoms—and can help ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Novo Nordisk said on Monday it would halt its collaboration with U.S. telehealth company Hims & Hers Health over the ...
Prescriptions for Mounjaro jabs, to help people lose weight, will be available at GP surgeries in England from today - but ...
Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...
People started on a low dose of Amgen's long-acting experimental obesity drug MariTide lost as much weight as those given ...
Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...
Amycretin helped patients lose over 24% of their weight, compared with an average of about 17% for Wegovy.
Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see ...
Whether it's Lizzo trimming her BMI or Jelly Roll dropping 200 pounds, these stars' weight loss journeys have produced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results